Welcome to LookChem.com Sign In|Join Free

CAS

  • or

269406-90-8

Post Buying Request

269406-90-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

269406-90-8 Usage

Description

(S)-Benzyloxycarbonylamino-cyclopropyl-acetic acid, also known as Boc-amino-cyclopropyl-acetic acid, is a chemical compound with the molecular formula C14H17NO4. It is a derivative of cyclopropane-based amino acids and is commonly used in the synthesis of pharmaceuticals and biologically active compounds. Boc-amino-cyclopropyl-acetic acid has potential applications in the development of new drug candidates, particularly in the field of protease inhibitors. (S)-Benzyloxycarbonylamino-cyclopropyl-acetic acid is known for its unique structure and pharmacological properties, making it a significant target for research and development in the pharmaceutical industry.

Uses

Used in Pharmaceutical Synthesis:
(S)-Benzyloxycarbonylamino-cyclopropyl-acetic acid is used as a building block for the synthesis of various pharmaceuticals and biologically active compounds. Its unique structure and properties allow for the creation of novel drug candidates with potential therapeutic applications.
Used in Protease Inhibitor Development:
In the field of protease inhibitors, (S)-Benzyloxycarbonylamino-cyclopropyl-acetic acid is used as a key component in the development of new drug candidates. Its interaction with protease enzymes can potentially lead to the development of treatments for various diseases and conditions where protease activity is a factor.
Used in Research and Development:
(S)-Benzyloxycarbonylamino-cyclopropyl-acetic acid is also used as a research tool in the pharmaceutical industry. Its unique structure and pharmacological properties make it an important compound for studying the mechanisms of action and potential applications of new drug candidates.

Check Digit Verification of cas no

The CAS Registry Mumber 269406-90-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,9,4,0 and 6 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 269406-90:
(8*2)+(7*6)+(6*9)+(5*4)+(4*0)+(3*6)+(2*9)+(1*0)=168
168 % 10 = 8
So 269406-90-8 is a valid CAS Registry Number.

269406-90-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-2-(benzyloxycarbonylamino)-2-cyclopropylacetic acid

1.2 Other means of identification

Product number -
Other names (S)-benzyloxycarbonylamino-cyclopropyl-acetic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:269406-90-8 SDS

269406-90-8Relevant articles and documents

PEPTIDOMIMETIC COMPOUNDS AND ANTIBODY-DRUG CONJUGATES THEREOF

-

Page/Page column 184; 185, (2015/07/07)

This invention relates to peptidomimetic linkers and anti-body drug conjugates thereof, to pharmaceutical compositions containing them, and to their use in therapy for the prevention or treatment of cancer.

INHIBITORS OF CATHEPSIN S

-

, (2008/06/13)

The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at least one other cathepsin isozyme. The present invention also provides methods for treating a disease state in a subject by selectively inhibiting cathepsin S.

INHIBITORS OF CATHEPSIN S

-

Page/Page column 42-43, (2008/06/13)

The present invention provides compounds, compositions and methods for the selective inhibition of cathepsin S. In a preferred aspect, cathepsin S is selectively inhibited in the presence of at least one other cathepsin isozyme. The present invention also provides methods for treating a disease state in a subject by selectively inhibiting cathepsin S.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 269406-90-8